<DOC>
	<DOCNO>NCT00243542</DOCNO>
	<brief_summary>The purpose study gather information safety ACZONE Gel , 5 % treat subject acne certain blood disorder . ACZONE Gel , 5 % prescription skin use ( topical ) medicine use help treat acne people 12 year old . ACZONE Gel , 5 % study approximately 4000 people show reduce number pimple improve acne . The active drug ingredient ACZONE Gel , 5 % dapsone . People blood disorder call `` G6PD deficiency '' , `` methemoglobin reductase deficiency '' , `` hemoglobin M '' high chance side effect dapsone . G6PD short `` glucose-6-phosphate dehydrogenase '' . It enzyme find red blood cell , carry oxygen part body . G6PD help red blood cell function normally . Some people le G6PD red blood cell average person . This call G6PD deficiency . Two treatment - ACZONE Gel , 5 % placebo - study comparison .</brief_summary>
	<brief_title>Phase IV Study Gather More Information About Safety ACZONE Gel , 5 % Treating Subjects With Acne Who Have G6PD Deficiency</brief_title>
	<detailed_description>Study Objectives : - To compare safety profile risk hemolysis ACZONE Gel , 5 % vehicle 12 week twice daily application acne vulgaris subject glucose-6-phosphate-dehydrogenase ( G6PD ) deficiency . - To determine systemic level plasma dapsone N-acetyl dapsone treatment ACZONE Gel , 5 % . Study Population : Approximately 60 male female subject Study Treatment : All subject study receive ACZONE Gel , 5 % vehicle 1 2 sequence ; 12-week period .</detailed_description>
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Glucosephosphate Dehydrogenase Deficiency</mesh_term>
	<mesh_term>Dapsone</mesh_term>
	<criteria>To eligible study , subject must fulfill follow criterion : 1 . Male female ≥12 year age . 2 . A clear diagnosis acne vulgaris , define ≥20 acne inflammatory and/or noninflammatory lesion ( ≥10 acne lesion must face , others may present neck , shoulder , upper chest , upper back ) screening . 3 . A diagnosis G6PD deficiency , define G6PD value lower limit normal central reference laboratory . Subjects meet follow criterion exclude study : 1 . A dermal examination reveals presence severe cystic acne acne conglobata . 2 . Treatment isotretinoin ( Accutane® ) within 3 month baseline throughout study . 3 . Subjects predispose anemia medical reason , include limited gastrointestinal bleeding cancer . 4 . Subjects use topical systemic medication acne throughout study . This include , limited , benzoyl peroxide , antibiotic , topical Vitamin A derivatives RetinA . 5 . Subjects use medication eat food could potentially cause hemolytic event individual G6PD deficiency study . 6 . Facial surgery ( dermabrasion , laser resurface facial cosmetic surgery ) within 3 month baseline throughout study . 7 . A history hypersensitivity dapsone , parabens , component study product .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Acne , G6PD deficiency , Dapsone</keyword>
</DOC>